Humabs BioMed, subsidiary of Vir Biotechnology reposted this
Our Executive Management Team spent a few days immersed in science with our colleagues at our research site in Bellinzona, Switzerland before heading to Milan for the #EASL Congress 2024. Our exceptional scientists in Bellinzona discovered and developed antibodies that have helped us transform the infectious disease landscape – from Ebola to COVID-19, with much more to come! Angie K. Aine Hanly Jason Franklyn Vanina de Verneuil Marianne D. De Backer, MSc, PhD, MBA Jennifer Towne Mark Eisner Jenny Gumm Ed.D. Brent Sabatini, CPA Corti Davide Carey Hwang, MD, PhD
